Historic Epilepsy Breakthrough: UK Schoolboy's Seizures Dramatically Reduced

A 13-year-old from south-west England, Oran Knowlson, has made medical history by trialing a neurostimulator to reduce severe epilepsy seizures. The device cut his seizures by 80%, significantly improving his quality of life. This trial at Great Ormond Street Hospital is part of the CADET project, targeting severe epilepsy in children.

A groundbreaking development in epilepsy treatment has been achieved by a schoolboy from south-west England. Oran Knowlson, aged 13, has become the first in the world to trial a neurostimulator implanted in his skull, designed to control severe epilepsy seizures.

The innovative device, which sends electrical signals deep into the brain, has successfully reduced Oran's daytime seizures by an impressive 80%. This pioneering surgery was conducted in October at Great Ormond Street Hospital in London, in collaboration with University College London, King's College Hospital, and the University of Oxford. It formed part of the CADET (Children’s Adaptive Deep Brain Stimulation for Epilepsy Trial) project.

Oran's mother, Justine, expressed her relief and joy, noting that her son's quality of life has significantly improved. "We’ve seen a big improvement, seizures are less severe, and he's a lot more chatty and engaged. He’s now a typical teenager, which is wonderful to see," she relayed to the BBC.